Keratoconus. When contact lenses are chosen for reasons other than the above, they are to be considered cosmetic in nature. Under these circumstances, an allowance of up to $130.00 will be made in lieu of the covered person's receipt of all other benefits for that time period.
Keratoconus. KeraVision has begun a clinical study in Europe using the Company's patented Intacs technology as a possible treatment for keratoconus, a progressive thinning-of-the-cornea disorder. Marketing and Sales United States Our U.S. marketing roll-out objective is to gain acceptance of Intacs by both ophthalmic surgeons and consumers. We have established two distribution channels to begin the initial marketing efforts to the estimated 8,000 ophthalmic surgeons, of which an estimated 2,000 are currently performing refractive surgery. The first channel is our direct sales force. We have added refractive surgery business specialists and manufacturers' representatives to market directly to
